Market Growing Debt Burden and Biotech Amgen’s Prospects Biotech Amgen Inc. (NASDAQ: AMGN) has been expanding its portfolio through acquisitions in recent years, giving it access to blockbuster drugs but also adding... Investa PortalApril 15, 2024